• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲醛处理蛋白质可通过限制抗原加工来抑制向T细胞的呈递。

Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.

作者信息

di Tommaso A, de Magistris M T, Bugnoli M, Marsili I, Rappuoli R, Abrignani S

机构信息

Immunobiology Research Institute Siena, Italy.

出版信息

Infect Immun. 1994 May;62(5):1830-4. doi: 10.1128/iai.62.5.1830-1834.1994.

DOI:10.1128/iai.62.5.1830-1834.1994
PMID:7513307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC186418/
Abstract

Proteins to be used as vaccines are frequently treated with formaldehyde, although little is known about the effects of this treatment on protein antigenicity. To investigate the effect of formaldehyde treatment on antigen recognition by T cells, we compared the in vitro T-cell response to proteins that have been formaldehyde treated with the response to untreated proteins. We found that peripheral blood mononuclear cells from individuals vaccinated with three formaldehyde-treated proteins (pertussis toxin, filamentous hemagglutinin, pertactin) of Bordetella pertussis showed little or no response to the formaldehyde-treated proteins but proliferated very well in response to the corresponding untreated protein. These findings were further confirmed with CD4+ T-cell clones specific for defined epitopes of the bacterial proteins. We found that some epitopes are presented poorly or not at all when formaldehyde-treated proteins are used, whereas other epitopes are equally presented to T-cell clones when either formaldehyde-treated or untreated antigens are used. However, T-cell recognition could be restored by either antigen degradation before formaldehyde treatment or heat denaturation after such treatment. Parallel digestion with trypsin of both formaldehyde-treated and untreated proteins showed that fragments generated from the two forms of the same antigen were different in size. These results demonstrate that formaldehyde treatment can constrain antigen presentation to T cells and that this may be due to an altered proteolytic processing of formaldehyde-treated proteins.

摘要

用作疫苗的蛋白质经常用甲醛处理,尽管对于这种处理对蛋白质抗原性的影响知之甚少。为了研究甲醛处理对T细胞抗原识别的影响,我们比较了体外T细胞对经甲醛处理的蛋白质与未经处理的蛋白质的反应。我们发现,接种了百日咳博德特氏菌的三种经甲醛处理的蛋白质(百日咳毒素、丝状血凝素、百日咳杆菌粘附素)的个体的外周血单核细胞对经甲醛处理的蛋白质几乎没有反应或完全没有反应,但对相应的未经处理的蛋白质反应良好。这些发现通过对细菌蛋白质特定表位具有特异性的CD4 + T细胞克隆得到了进一步证实。我们发现,当使用经甲醛处理的蛋白质时,一些表位的呈递较差或根本不呈递,而当使用经甲醛处理或未经处理的抗原时,其他表位对T细胞克隆的呈递相同。然而,T细胞识别可以通过甲醛处理前的抗原降解或处理后的热变性来恢复。对经甲醛处理和未经处理的蛋白质进行胰蛋白酶平行消化表明,同一抗原的两种形式产生的片段大小不同。这些结果表明,甲醛处理会限制抗原向T细胞的呈递,这可能是由于经甲醛处理的蛋白质的蛋白水解加工改变所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b6/186418/94f347a7f88d/iai00005-0341-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b6/186418/196cf48eebdb/iai00005-0340-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b6/186418/94f347a7f88d/iai00005-0341-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b6/186418/196cf48eebdb/iai00005-0340-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21b6/186418/94f347a7f88d/iai00005-0341-a.jpg

相似文献

1
Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.甲醛处理蛋白质可通过限制抗原加工来抑制向T细胞的呈递。
Infect Immun. 1994 May;62(5):1830-4. doi: 10.1128/iai.62.5.1830-1834.1994.
2
Dissecting human T cell responses against Bordetella species.剖析人类针对博德特氏菌属的T细胞反应。
J Exp Med. 1988 Oct 1;168(4):1351-62. doi: 10.1084/jem.168.4.1351.
3
Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.健康成年人对百日咳博德特氏菌疫苗抗原的细胞介导免疫反应。
J Infect Dis. 1998 Aug;178(2):466-70. doi: 10.1086/515628.
4
Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice.调查鲍特菌属百日咳丝状血凝素和 pertactin 的重组片段在 BALB/c 小鼠中的细胞免疫应答。
J Interferon Cytokine Res. 2018 Apr;38(4):161-170. doi: 10.1089/jir.2017.0060.
5
Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment.百日咳毒素突变体PT-9K/129G经甲醛处理后的特性
Infect Immun. 1991 Feb;59(2):625-30. doi: 10.1128/iai.59.2.625-630.1991.
6
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.由基因灭活百日咳毒素与丝状血凝素及百日咳杆菌黏附素组成的无细胞百日咳疫苗在婴幼儿中的免疫原性。
J Pediatr. 1993 Jul;123(1):81-4. doi: 10.1016/s0022-3476(05)81543-4.
7
The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.细菌毒素与甲醛的反应及其在抗原稳定化中的应用。
Dev Biol Stand. 1996;87:125-34.
8
Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.百日咳患儿血清中针对百日咳毒素、丝状血凝素和百日咳杆菌黏附素的IgG抗体反应及下降情况
Scand J Infect Dis. 1995;27(3):273-7. doi: 10.3109/00365549509019021.
9
Human T cell immunity against Bordetella pertussis analyzed at clonal level.在克隆水平分析人类针对百日咳博德特氏菌的T细胞免疫。
Ann Ist Super Sanita. 1991;27(1):33-6.
10
Determination of pertactin IgG antibodies for the diagnosis of pertussis.用于百日咳诊断的百日咳杆菌黏附素IgG抗体的检测
Clin Microbiol Infect. 2003 Jul;9(7):585-9. doi: 10.1046/j.1469-0691.2003.00552.x.

引用本文的文献

1
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.化学交联的HIV-1包膜糖蛋白实验性疫苗抗原的深度结构保守性
NPJ Vaccines. 2023 Jul 13;8(1):101. doi: 10.1038/s41541-023-00696-w.
2
, classification, pathogenesis, immune response, and trends in vaccine development.分类、发病机制、免疫反应及疫苗研发趋势。
Front Med (Lausanne). 2023 May 5;10:1155751. doi: 10.3389/fmed.2023.1155751. eCollection 2023.
3
Novel Proteoliposome-Based Vaccine against : A Potential New Tool for the Control of Bovine Mastitis.

本文引用的文献

1
Antigen-presenting function of the macrophage.巨噬细胞的抗原呈递功能。
Annu Rev Immunol. 1984;2:395-428. doi: 10.1146/annurev.iy.02.040184.002143.
2
Development of a pertussis component vaccine in Japan.日本百日咳组分疫苗的研发。
Lancet. 1984 Jan 21;1(8369):122-6. doi: 10.1016/s0140-6736(84)90061-8.
3
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
新型基于蛋白脂质体的疫苗对抗:控制奶牛乳腺炎的潜在新工具。
Animals (Basel). 2022 Sep 22;12(19):2533. doi: 10.3390/ani12192533.
4
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Immunity.评价一种针对 Q 热的人 T 细胞靶向多表位疫苗在免疫动物模型中的效果。
Front Immunol. 2022 May 16;13:901372. doi: 10.3389/fimmu.2022.901372. eCollection 2022.
5
A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen.一种用于检测破伤风类毒素疫苗抗原免疫完整性的基于细胞的体外检测方法。
NPJ Vaccines. 2021 Jun 23;6(1):88. doi: 10.1038/s41541-021-00344-1.
6
Impact of Protein Glycosylation on the Design of Viral Vaccines.蛋白质糖基化对病毒疫苗设计的影响。
Adv Biochem Eng Biotechnol. 2021;175:319-354. doi: 10.1007/10_2020_132.
7
Pertussis Toxin: A Key Component in Pertussis Vaccines?百日咳毒素:百日咳疫苗中的关键成分?
Toxins (Basel). 2019 Sep 21;11(10):557. doi: 10.3390/toxins11100557.
8
Glutaraldehyde Cross-linking of HIV-1 Env Trimers Skews the Antibody Subclass Response in Mice.HIV-1包膜三聚体的戊二醛交联使小鼠抗体亚类反应发生偏向。
Front Immunol. 2017 Nov 27;8:1654. doi: 10.3389/fimmu.2017.01654. eCollection 2017.
9
Development of a subunit vaccine for prevention of associated diseases: Biophysical characterization of toxoids A and B.开发用于预防相关疾病的亚单位疫苗:类毒素A和B的生物物理特性
Biochem Biophys Rep. 2017 Jan 5;9:193-202. doi: 10.1016/j.bbrep.2016.12.015. eCollection 2017 Mar.
10
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.一种破伤风、白喉、重组无细胞百日咳联合疫苗(TdaP)在泰国健康成年人中的安全性和免疫原性。
Hum Vaccin Immunother. 2017 Jan 2;13(1):136-143. doi: 10.1080/21645515.2016.1234555. Epub 2016 Sep 29.
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
4
Dissecting human T cell responses against Bordetella species.剖析人类针对博德特氏菌属的T细胞反应。
J Exp Med. 1988 Oct 1;168(4):1351-62. doi: 10.1084/jem.168.4.1351.
5
Mutants of pertussis toxin suitable for vaccine development.适用于疫苗研发的百日咳毒素突变体。
Science. 1989 Oct 27;246(4929):497-500. doi: 10.1126/science.2683073.
6
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.人类T细胞克隆将百日咳毒素的S1亚基定义为免疫原性最强的部分,并确定了其表位图谱。
J Exp Med. 1989 May 1;169(5):1519-32. doi: 10.1084/jem.169.5.1519.
7
Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor.
Mol Microbiol. 1990 May;4(5):787-800. doi: 10.1111/j.1365-2958.1990.tb00649.x.
8
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.用基因灭活的百日咳毒素突变体PT-9K/129G免疫的成年志愿者的代谢、体液和细胞反应。
J Exp Med. 1990 Sep 1;172(3):861-8. doi: 10.1084/jem.172.3.861.
9
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.由基因解毒百日咳毒素与丝状血凝素(FHA)及69千道尔顿蛋白组合而成的无细胞百日咳疫苗的I期临床试验。
Vaccine. 1991 Oct;9(10):741-5. doi: 10.1016/0264-410x(91)90290-m.
10
N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.HIV-gp120的N-糖基化可能会限制T淋巴细胞的识别。
J Immunol. 1991 Nov 1;147(9):3128-32.